Industry Research Reports

Home > Reports > Service & Software > Global Cancer Diagnostics Service Market Research Report 2026

Global Cancer Diagnostics Service Market Research Report 2026

Industry: Service & Software

Published Date: 2026-03-06

Pages: 127 Pages

Report ld: 6023887

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Cancer Diagnostics Service Market Size(US$)

CAGR 2026-2032

9.9%

Market Size,2032

USD 294,080

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 167,280 million

Market Forecast in 2032(Value)

US$ 294,080 million

CAGR

9.9%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Cancer Diagnostics Service market was valued at US$ 153640 million in 2025 and is anticipated to reach US$ 294080 million by 2032, at a CAGR of 9.9% from 2026 to 2032.

Cancer diagnostic services refer to medical technology services that utilize imaging examinations (such as CT, MRI, PET-CT) and in vitro diagnostics (including tumor marker detection, liquid biopsy, gene sequencing, pathological sections, and molecular subtyping) to provide early cancer screening, diagnosis, subtyping, staging, and medication guidance for suspected or high-risk individuals. This encompasses the entire process from sample collection and laboratory analysis to clinical interpretation. The upstream of the industry chain includes suppliers of high-throughput sequencers (Illumina, Thermo Fisher), antibody reagents, fluorescent probes, pathology equipment, AI-assisted diagnostic algorithms, and bioinformatics databases. The midstream consists of diagnostic service providers, who must possess CAP/CLIA or China National Institutes for Clinical Laboratories certification, NGS platforms, bioinformatics analysis capabilities, and compliant data management systems. The downstream primarily targets hospitals, health checkup centers, pharmaceutical companies (with companion diagnostics collaborations), and individual consumers. Due to its technology-intensive nature, high licensing barriers, and the inclusion of some services in medical insurance, the industry's overall gross profit margin is between 50% and 75%, with routine pathology and immunohistochemistry gross profit margins around 40%–60%, while NGS-based multi-cancer early screening or MRD monitoring services can achieve gross profit margins exceeding 70%.

The Cancer Diagnostics Service market is expanding rapidly due to the rising global cancer incidence, aging populations, and increasing demand for early detection. Advances in molecular diagnostics, next-generation sequencing, and liquid biopsy technologies are transforming traditional cancer testing into more precise and less invasive approaches. Governments are strengthening cancer screening programs, while precision medicine is driving higher demand for companion diagnostics. Additionally, AI-powered imaging analysis and digital pathology platforms are improving diagnostic efficiency and accuracy. In the future, integrated multi-omics diagnostics and personalized cancer screening solutions will further drive sustained growth of the global cancer diagnostics service market.

This report delivers a comprehensive overview of the global Cancer Diagnostics Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cancer Diagnostics Service. The Cancer Diagnostics Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cancer Diagnostics Service market comprehensively. Regional market sizes by Type, by Application, by Diagnostic Technology, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Cancer Diagnostics Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Illumina
BGI Genomics Co.,Ltd.
Agilent Technologies
Macrogen
UCSF Health
Abbott
QIAGEN
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
Applied DNA Sciences
TherapySelect
Caris Life Sciences
Foresight Diagnostics
Smartpraxis
Amadix
Check4Cancer
Hologic
RGCC
ICON

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Breast Cancer
Blood Cancer
Lung Cancer
Colorectal Cancer
Ovarian Cancer
Others

Segment by Application

Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories
Others

Segment by Category

Imaging-based Cancer Diagnostics
Pathology-based Cancer Diagnostics
Molecular Cancer Diagnostics
Biomarker-based Cancer Diagnostics

Segment by Division

Genetic Testing
Liquid Biopsy
Tissue Biopsy
Immunohistochemistry (IHC)

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Diagnostic Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Cancer Diagnostics Service companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Diagnostics Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Breast Cancer

1.2.3 Blood Cancer

1.2.4 Lung Cancer

1.2.5 Colorectal Cancer

1.2.6 Ovarian Cancer

1.2.7 Others

1.3 Market by Diagnostic Technology

1.3.1 Global Cancer Diagnostics Service Market Size Growth Rate by Diagnostic Technology: 2021 vs 2025 vs 2032

1.3.2 Imaging-based Cancer Diagnostics

1.3.3 Pathology-based Cancer Diagnostics

1.3.4 Molecular Cancer Diagnostics

1.3.5 Biomarker-based Cancer Diagnostics

1.4 Market by Testing Method

1.4.1 Global Cancer Diagnostics Service Market Size Growth Rate by Testing Method: 2021 vs 2025 vs 2032

1.4.2 Genetic Testing

1.4.3 Liquid Biopsy

1.4.4 Tissue Biopsy

1.4.5 Immunohistochemistry (IHC)

1.5 Market by Application

1.5.1 Global Cancer Diagnostics Service Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Hospitals

1.5.3 Ambulatory Surgical Centers

1.5.4 Diagnostic Laboratories

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Cancer Diagnostics Service Market Perspective (2021–2032)

2.2 Global Cancer Diagnostics Service Growth Trends by Region

2.2.1 Global Cancer Diagnostics Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Cancer Diagnostics Service Historic Market Size by Region (2021–2026)

2.2.3 Cancer Diagnostics Service Forecasted Market Size by Region (2027–2032)

2.3 Cancer Diagnostics Service Market Dynamics

2.3.1 Cancer Diagnostics Service Industry Trends

2.3.2 Cancer Diagnostics Service Market Drivers

2.3.3 Cancer Diagnostics Service Market Challenges

2.3.4 Cancer Diagnostics Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Diagnostics Service Players by Revenue

3.1.1 Global Top Cancer Diagnostics Service Players by Revenue (2021–2026)

3.1.2 Global Cancer Diagnostics Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Cancer Diagnostics Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Cancer Diagnostics Service Revenue

3.4 Global Cancer Diagnostics Service Market Concentration Ratio

3.4.1 Global Cancer Diagnostics Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Service Revenue in 2025

3.5 Global Key Players of Cancer Diagnostics Service Head Offices and Areas Served

3.6 Global Key Players of Cancer Diagnostics Service, Products and Applications

3.7 Global Key Players of Cancer Diagnostics Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Cancer Diagnostics Service Breakdown Data by Type

4.1 Global Cancer Diagnostics Service Historic Market Size by Type (2021–2026)

4.2 Global Cancer Diagnostics Service Forecasted Market Size by Type (2027–2032)

5 Cancer Diagnostics Service Breakdown Data by Application

5.1 Global Cancer Diagnostics Service Historic Market Size by Application (2021–2026)

5.2 Global Cancer Diagnostics Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Cancer Diagnostics Service Market Size (2021–2032)

6.2 North America Cancer Diagnostics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Cancer Diagnostics Service Market Size by Country (2021–2026)

6.4 North America Cancer Diagnostics Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Diagnostics Service Market Size (2021–2032)

7.2 Europe Cancer Diagnostics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Cancer Diagnostics Service Market Size by Country (2021–2026)

7.4 Europe Cancer Diagnostics Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Cancer Diagnostics Service Market Size (2021–2032)

8.2 Asia-Pacific Cancer Diagnostics Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Cancer Diagnostics Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Cancer Diagnostics Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Cancer Diagnostics Service Market Size (2021–2032)

9.2 Latin America Cancer Diagnostics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Cancer Diagnostics Service Market Size by Country (2021–2026)

9.4 Latin America Cancer Diagnostics Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Diagnostics Service Market Size (2021–2032)

10.2 Middle East & Africa Cancer Diagnostics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina Cancer Diagnostics Service Introduction

11.1.4 Illumina Revenue in Cancer Diagnostics Service Business (2021–2026)

11.1.5 Illumina Recent Development

11.2 BGI Genomics Co.,Ltd.

11.2.1 BGI Genomics Co.,Ltd. Company Details

11.2.2 BGI Genomics Co.,Ltd. Business Overview

11.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Introduction

11.2.4 BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2021–2026)

11.2.5 BGI Genomics Co.,Ltd. Recent Development

11.3 Agilent Technologies

11.3.1 Agilent Technologies Company Details

11.3.2 Agilent Technologies Business Overview

11.3.3 Agilent Technologies Cancer Diagnostics Service Introduction

11.3.4 Agilent Technologies Revenue in Cancer Diagnostics Service Business (2021–2026)

11.3.5 Agilent Technologies Recent Development

11.4 Macrogen

11.4.1 Macrogen Company Details

11.4.2 Macrogen Business Overview

11.4.3 Macrogen Cancer Diagnostics Service Introduction

11.4.4 Macrogen Revenue in Cancer Diagnostics Service Business (2021–2026)

11.4.5 Macrogen Recent Development

11.5 UCSF Health

11.5.1 UCSF Health Company Details

11.5.2 UCSF Health Business Overview

11.5.3 UCSF Health Cancer Diagnostics Service Introduction

11.5.4 UCSF Health Revenue in Cancer Diagnostics Service Business (2021–2026)

11.5.5 UCSF Health Recent Development

11.6 Abbott

11.6.1 Abbott Company Details

11.6.2 Abbott Business Overview

11.6.3 Abbott Cancer Diagnostics Service Introduction

11.6.4 Abbott Revenue in Cancer Diagnostics Service Business (2021–2026)

11.6.5 Abbott Recent Development

11.7 QIAGEN

11.7.1 QIAGEN Company Details

11.7.2 QIAGEN Business Overview

11.7.3 QIAGEN Cancer Diagnostics Service Introduction

11.7.4 QIAGEN Revenue in Cancer Diagnostics Service Business (2021–2026)

11.7.5 QIAGEN Recent Development

11.8 Siemens Healthcare GmbH

11.8.1 Siemens Healthcare GmbH Company Details

11.8.2 Siemens Healthcare GmbH Business Overview

11.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Introduction

11.8.4 Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2021–2026)

11.8.5 Siemens Healthcare GmbH Recent Development

11.9 Thermo Fisher Scientific, Inc.

11.9.1 Thermo Fisher Scientific, Inc. Company Details

11.9.2 Thermo Fisher Scientific, Inc. Business Overview

11.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Introduction

11.9.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2021–2026)

11.9.5 Thermo Fisher Scientific, Inc. Recent Development

11.10 Applied DNA Sciences

11.10.1 Applied DNA Sciences Company Details

11.10.2 Applied DNA Sciences Business Overview

11.10.3 Applied DNA Sciences Cancer Diagnostics Service Introduction

11.10.4 Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2021–2026)

11.10.5 Applied DNA Sciences Recent Development

11.11 TherapySelect

11.11.1 TherapySelect Company Details

11.11.2 TherapySelect Business Overview

11.11.3 TherapySelect Cancer Diagnostics Service Introduction

11.11.4 TherapySelect Revenue in Cancer Diagnostics Service Business (2021–2026)

11.11.5 TherapySelect Recent Development

11.12 Caris Life Sciences

11.12.1 Caris Life Sciences Company Details

11.12.2 Caris Life Sciences Business Overview

11.12.3 Caris Life Sciences Cancer Diagnostics Service Introduction

11.12.4 Caris Life Sciences Revenue in Cancer Diagnostics Service Business (2021–2026)

11.12.5 Caris Life Sciences Recent Development

11.13 Foresight Diagnostics

11.13.1 Foresight Diagnostics Company Details

11.13.2 Foresight Diagnostics Business Overview

11.13.3 Foresight Diagnostics Cancer Diagnostics Service Introduction

11.13.4 Foresight Diagnostics Revenue in Cancer Diagnostics Service Business (2021–2026)

11.13.5 Foresight Diagnostics Recent Development

11.14 Smartpraxis

11.14.1 Smartpraxis Company Details

11.14.2 Smartpraxis Business Overview

11.14.3 Smartpraxis Cancer Diagnostics Service Introduction

11.14.4 Smartpraxis Revenue in Cancer Diagnostics Service Business (2021–2026)

11.14.5 Smartpraxis Recent Development

11.15 Amadix

11.15.1 Amadix Company Details

11.15.2 Amadix Business Overview

11.15.3 Amadix Cancer Diagnostics Service Introduction

11.15.4 Amadix Revenue in Cancer Diagnostics Service Business (2021–2026)

11.15.5 Amadix Recent Development

11.16 Check4Cancer

11.16.1 Check4Cancer Company Details

11.16.2 Check4Cancer Business Overview

11.16.3 Check4Cancer Cancer Diagnostics Service Introduction

11.16.4 Check4Cancer Revenue in Cancer Diagnostics Service Business (2021–2026)

11.16.5 Check4Cancer Recent Development

11.17 Hologic

11.17.1 Hologic Company Details

11.17.2 Hologic Business Overview

11.17.3 Hologic Cancer Diagnostics Service Introduction

11.17.4 Hologic Revenue in Cancer Diagnostics Service Business (2021–2026)

11.17.5 Hologic Recent Development

11.18 RGCC

11.18.1 RGCC Company Details

11.18.2 RGCC Business Overview

11.18.3 RGCC Cancer Diagnostics Service Introduction

11.18.4 RGCC Revenue in Cancer Diagnostics Service Business (2021–2026)

11.18.5 RGCC Recent Development

11.19 ICON

11.19.1 ICON Company Details

11.19.2 ICON Business Overview

11.19.3 ICON Cancer Diagnostics Service Introduction

11.19.4 ICON Revenue in Cancer Diagnostics Service Business (2021–2026)

11.19.5 ICON Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Cancer Diagnostics Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Breast Cancer

Table 3. Key Players of Blood Cancer

Table 4. Key Players of Lung Cancer

Table 5. Key Players of Colorectal Cancer

Table 6. Key Players of Ovarian Cancer

Table 7. Key Players of Others

Table 8. Global Cancer Diagnostics Service Market Size Growth Rate by Diagnostic Technology (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of Imaging-based Cancer Diagnostics

Table 10. Key Players of Pathology-based Cancer Diagnostics

Table 11. Key Players of Molecular Cancer Diagnostics

Table 12. Key Players of Biomarker-based Cancer Diagnostics

Table 13. Global Cancer Diagnostics Service Market Size Growth Rate by Testing Method (US$ Million): 2021 vs 2025 vs 2032

Table 14. Key Players of Genetic Testing

Table 15. Key Players of Liquid Biopsy

Table 16. Key Players of Tissue Biopsy

Table 17. Key Players of Immunohistochemistry (IHC)

Table 18. Global Cancer Diagnostics Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Cancer Diagnostics Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 20. Global Cancer Diagnostics Service Market Size by Region (US$ Million), 2021–2026

Table 21. Global Cancer Diagnostics Service Market Share by Region (2021–2026)

Table 22. Global Cancer Diagnostics Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 23. Global Cancer Diagnostics Service Market Share by Region (2027–2032)

Table 24. Cancer Diagnostics Service Market Trends

Table 25. Cancer Diagnostics Service Market Drivers

Table 26. Cancer Diagnostics Service Market Challenges

Table 27. Cancer Diagnostics Service Market Restraints

Table 28. Global Cancer Diagnostics Service Revenue by Players (US$ Million), 2021–2026

Table 29. Global Cancer Diagnostics Service Market Share by Players (2021–2026)

Table 30. Global Top Cancer Diagnostics Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cancer Diagnostics Service Revenue, 2025

Table 31. Ranking of Global Top Cancer Diagnostics Service Companies by Revenue (US$ Million) in 2025

Table 32. Global 5 Largest Players Market Share by Cancer Diagnostics Service Revenue (CR5 and HHI), 2021–2026

Table 33. Global Key Players of Cancer Diagnostics Service, Headquarters and Area Served

Table 34. Global Key Players of Cancer Diagnostics Service, Products and Applications

Table 35. Global Key Players of Cancer Diagnostics Service, Date of General Availability (GA)

Table 36. Mergers and Acquisitions, Expansion Plans

Table 37. Global Cancer Diagnostics Service Market Size by Type (US$ Million), 2021–2026

Table 38. Global Cancer Diagnostics Service Revenue Market Share by Type (2021–2026)

Table 39. Global Cancer Diagnostics Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 40. Global Cancer Diagnostics Service Revenue Market Share by Type (2027–2032)

Table 41. Global Cancer Diagnostics Service Market Size by Application (US$ Million), 2021–2026

Table 42. Global Cancer Diagnostics Service Revenue Market Share by Application (2021–2026)

Table 43. Global Cancer Diagnostics Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 44. Global Cancer Diagnostics Service Revenue Market Share by Application (2027–2032)

Table 45. North America Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. North America Cancer Diagnostics Service Market Size by Country (US$ Million), 2021–2026

Table 47. North America Cancer Diagnostics Service Market Size by Country (US$ Million), 2027–2032

Table 48. Europe Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Europe Cancer Diagnostics Service Market Size by Country (US$ Million), 2021–2026

Table 50. Europe Cancer Diagnostics Service Market Size by Country (US$ Million), 2027–2032

Table 51. Asia-Pacific Cancer Diagnostics Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 52. Asia-Pacific Cancer Diagnostics Service Market Size by Region (US$ Million), 2021–2026

Table 53. Asia-Pacific Cancer Diagnostics Service Market Size by Region (US$ Million), 2027–2032

Table 54. Latin America Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Latin America Cancer Diagnostics Service Market Size by Country (US$ Million), 2021–2026

Table 56. Latin America Cancer Diagnostics Service Market Size by Country (US$ Million), 2027–2032

Table 57. Middle East & Africa Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 58. Middle East & Africa Cancer Diagnostics Service Market Size by Country (US$ Million), 2021–2026

Table 59. Middle East & Africa Cancer Diagnostics Service Market Size by Country (US$ Million), 2027–2032

Table 60. Illumina Company Details

Table 61. Illumina Business Overview

Table 62. Illumina Cancer Diagnostics Service Product

Table 63. Illumina Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 64. Illumina Recent Development

Table 65. BGI Genomics Co.,Ltd. Company Details

Table 66. BGI Genomics Co.,Ltd. Business Overview

Table 67. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product

Table 68. BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 69. BGI Genomics Co.,Ltd. Recent Development

Table 70. Agilent Technologies Company Details

Table 71. Agilent Technologies Business Overview

Table 72. Agilent Technologies Cancer Diagnostics Service Product

Table 73. Agilent Technologies Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 74. Agilent Technologies Recent Development

Table 75. Macrogen Company Details

Table 76. Macrogen Business Overview

Table 77. Macrogen Cancer Diagnostics Service Product

Table 78. Macrogen Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 79. Macrogen Recent Development

Table 80. UCSF Health Company Details

Table 81. UCSF Health Business Overview

Table 82. UCSF Health Cancer Diagnostics Service Product

Table 83. UCSF Health Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 84. UCSF Health Recent Development

Table 85. Abbott Company Details

Table 86. Abbott Business Overview

Table 87. Abbott Cancer Diagnostics Service Product

Table 88. Abbott Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 89. Abbott Recent Development

Table 90. QIAGEN Company Details

Table 91. QIAGEN Business Overview

Table 92. QIAGEN Cancer Diagnostics Service Product

Table 93. QIAGEN Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 94. QIAGEN Recent Development

Table 95. Siemens Healthcare GmbH Company Details

Table 96. Siemens Healthcare GmbH Business Overview

Table 97. Siemens Healthcare GmbH Cancer Diagnostics Service Product

Table 98. Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 99. Siemens Healthcare GmbH Recent Development

Table 100. Thermo Fisher Scientific, Inc. Company Details

Table 101. Thermo Fisher Scientific, Inc. Business Overview

Table 102. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product

Table 103. Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 104. Thermo Fisher Scientific, Inc. Recent Development

Table 105. Applied DNA Sciences Company Details

Table 106. Applied DNA Sciences Business Overview

Table 107. Applied DNA Sciences Cancer Diagnostics Service Product

Table 108. Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 109. Applied DNA Sciences Recent Development

Table 110. TherapySelect Company Details

Table 111. TherapySelect Business Overview

Table 112. TherapySelect Cancer Diagnostics Service Product

Table 113. TherapySelect Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 114. TherapySelect Recent Development

Table 115. Caris Life Sciences Company Details

Table 116. Caris Life Sciences Business Overview

Table 117. Caris Life Sciences Cancer Diagnostics Service Product

Table 118. Caris Life Sciences Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 119. Caris Life Sciences Recent Development

Table 120. Foresight Diagnostics Company Details

Table 121. Foresight Diagnostics Business Overview

Table 122. Foresight Diagnostics Cancer Diagnostics Service Product

Table 123. Foresight Diagnostics Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 124. Foresight Diagnostics Recent Development

Table 125. Smartpraxis Company Details

Table 126. Smartpraxis Business Overview

Table 127. Smartpraxis Cancer Diagnostics Service Product

Table 128. Smartpraxis Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 129. Smartpraxis Recent Development

Table 130. Amadix Company Details

Table 131. Amadix Business Overview

Table 132. Amadix Cancer Diagnostics Service Product

Table 133. Amadix Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 134. Amadix Recent Development

Table 135. Check4Cancer Company Details

Table 136. Check4Cancer Business Overview

Table 137. Check4Cancer Cancer Diagnostics Service Product

Table 138. Check4Cancer Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 139. Check4Cancer Recent Development

Table 140. Hologic Company Details

Table 141. Hologic Business Overview

Table 142. Hologic Cancer Diagnostics Service Product

Table 143. Hologic Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 144. Hologic Recent Development

Table 145. RGCC Company Details

Table 146. RGCC Business Overview

Table 147. RGCC Cancer Diagnostics Service Product

Table 148. RGCC Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 149. RGCC Recent Development

Table 150. ICON Company Details

Table 151. ICON Business Overview

Table 152. ICON Cancer Diagnostics Service Product

Table 153. ICON Revenue in Cancer Diagnostics Service Business (US$ Million), 2021–2026

Table 154. ICON Recent Development

Table 155. Research Programs/Design for This Report

Table 156. Key Data Information from Secondary Sources

Table 157. Key Data Information from Primary Sources

Table 158. Authors List of This Report

List of Figures

Figure 1. Cancer Diagnostics Service Picture

Figure 2. Global Cancer Diagnostics Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Cancer Diagnostics Service Market Share by Type: 2025 vs 2032

Figure 4. Breast Cancer Features

Figure 5. Blood Cancer Features

Figure 6. Lung Cancer Features

Figure 7. Colorectal Cancer Features

Figure 8. Ovarian Cancer Features

Figure 9. Others Features

Figure 10. Global Cancer Diagnostics Service Market Size Comparison by Diagnostic Technology (US$ Million), 2021–2032

Figure 11. Imaging-based Cancer Diagnostics Features

Figure 12. Pathology-based Cancer Diagnostics Features

Figure 13. Molecular Cancer Diagnostics Features

Figure 14. Biomarker-based Cancer Diagnostics Features

Figure 15. Global Cancer Diagnostics Service Market Size Comparison by Testing Method (US$ Million), 2021–2032

Figure 16. Genetic Testing Features

Figure 17. Liquid Biopsy Features

Figure 18. Tissue Biopsy Features

Figure 19. Immunohistochemistry (IHC) Features

Figure 20. Global Cancer Diagnostics Service Market Size by Application (US$ Million), 2021–2032

Figure 21. Global Cancer Diagnostics Service Market Share by Application: 2025 vs 2032

Figure 22. Hospitals Case Studies

Figure 23. Ambulatory Surgical Centers Case Studies

Figure 24. Diagnostic Laboratories Case Studies

Figure 25. Others Case Studies

Figure 26. Cancer Diagnostics Service Report Years Considered

Figure 27. Global Cancer Diagnostics Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 28. Global Cancer Diagnostics Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 29. Global Cancer Diagnostics Service Market Share by Region: 2025 vs 2032

Figure 30. Global Cancer Diagnostics Service Market Share by Players in 2025

Figure 31. Global Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 32. The Top 10 and 5 Players Market Share by Cancer Diagnostics Service Revenue in 2025

Figure 33. North America Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. North America Cancer Diagnostics Service Market Share by Country (2021–2032)

Figure 35. United States Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Canada Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Europe Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Europe Cancer Diagnostics Service Market Share by Country (2021–2032)

Figure 39. Germany Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. France Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. U.K. Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Italy Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Russia Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Ireland Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Asia-Pacific Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Asia-Pacific Cancer Diagnostics Service Market Share by Region (2021–2032)

Figure 47. China Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Japan Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. South Korea Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Southeast Asia Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. India Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Australia & New Zealand Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Latin America Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Latin America Cancer Diagnostics Service Market Share by Country (2021–2032)

Figure 55. Mexico Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Brazil Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Middle East & Africa Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Middle East & Africa Cancer Diagnostics Service Market Share by Country (2021–2032)

Figure 59. Israel Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 60. Saudi Arabia Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 61. UAE Cancer Diagnostics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 62. Illumina Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 63. BGI Genomics Co.,Ltd. Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 64. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 65. Macrogen Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 66. UCSF Health Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 67. Abbott Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 68. QIAGEN Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 69. Siemens Healthcare GmbH Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 70. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 71. Applied DNA Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 72. TherapySelect Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 73. Caris Life Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 74. Foresight Diagnostics Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 75. Smartpraxis Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 76. Amadix Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 77. Check4Cancer Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 78. Hologic Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 79. RGCC Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 80. ICON Revenue Growth Rate in Cancer Diagnostics Service Business (2021–2026)

Figure 81. Bottom-up and Top-down Approaches for This Report

Figure 82. Data Triangulation

Figure 83. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Cancer Diagnostics Service market? zhanKai

The top companies in the global Cancer Diagnostics Service market are Illumina、BGI Genomics Co.,Ltd.、Agilent Technologies.

What was the global market size of Cancer Diagnostics Service in 2026? shouQi

What was the global market size of Cancer Diagnostics Service in 2032? shouQi

What is the annual compound growth rate of the global Cancer Diagnostics Service market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cancer Diagnostics Service market size was US$ 153640 million in 2025 and is forecast to reach a readjusted size of US$ 294080 million by 2032 with a CAGR of 9.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 105
USD 4250.00
(Single User License)
Cancer Diagnostics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cancer Diagnostics Service was estimated to be worth US$ 153640 million in 2025 and is projected to reach US$ 294080 million, growing at a CAGR of 9.9% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 128
USD 3950.00
(Single User License)
Cancer Diagnostics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cancer Diagnostics Service was estimated to be worth US$ 39676 million in 2024 and is forecast to a readjusted size of US$ 270115 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 132
USD 3950.00
(Single User License)
Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cancer Diagnostics Service market size was US$ 39676 million in 2024 and is forecast to a readjusted size of US$ 270115 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published Date: 2025-12-12
Pages: 110
USD 4250.00
(Single User License)
Global Cancer Diagnostics Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cancer Diagnostics Service market is projected to grow from US$ 39676 million in 2024 to US$ 270115 million by 2031, at a CAGR of 9.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-12-12
Pages: 159
USD 4900.00
(Single User License)
Global Cancer Diagnostics Service Market Research Report 2025
The global market for Cancer Diagnostics Service was valued at US$ 39676 million in the year 2024 and is projected to reach a revised size of US$ 270115 million by 2031, growing at a CAGR of 9.9% during the forecast period.
Published Date: 2025-12-12
Pages: 139
USD 2900.00
(Single User License)
Cancer Diagnostics Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cancer Diagnostics Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-04
Pages: 96
USD 3950.00
(Single User License)
Global Cancer Diagnostics Service Market Insights, Forecast to 2030
Market Analysis and Insights: Global Cancer Diagnostics Service Market
Published Date: 2024-04-09
Pages: 105
USD 4900.00
(Single User License)
Global Cancer Diagnostics Service Market Research Report 2024
The global Cancer Diagnostics Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-08
Pages: 83
USD 2900.00
(Single User License)

Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cancer Diagnostics Service market size was US$ 153640 million in 2025 and is forecast to reach a readjusted size of US$ 294080 million by 2032 with a CAGR of 9.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 105
USD 4250.00 (Single User License)
Cancer Diagnostics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cancer Diagnostics Service was estimated to be worth US$ 153640 million in 2025 and is projected to reach US$ 294080 million, growing at a CAGR of 9.9% from 2026 to 2032.
Published: 2026-03-06
Pages: 128
USD 3950.00 (Single User License)
Cancer Diagnostics Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cancer Diagnostics Service was estimated to be worth US$ 39676 million in 2024 and is forecast to a readjusted size of US$ 270115 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 132
USD 3950.00 (Single User License)
Global Cancer Diagnostics Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cancer Diagnostics Service market size was US$ 39676 million in 2024 and is forecast to a readjusted size of US$ 270115 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031.
Published: 2025-12-12
Pages: 110
USD 4250.00 (Single User License)
Global Cancer Diagnostics Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cancer Diagnostics Service market is projected to grow from US$ 39676 million in 2024 to US$ 270115 million by 2031, at a CAGR of 9.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-12-12
Pages: 159
USD 4900.00 (Single User License)
Global Cancer Diagnostics Service Market Research Report 2025
The global market for Cancer Diagnostics Service was valued at US$ 39676 million in the year 2024 and is projected to reach a revised size of US$ 270115 million by 2031, growing at a CAGR of 9.9% during the forecast period.
Published: 2025-12-12
Pages: 139
USD 2900.00 (Single User License)
Cancer Diagnostics Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cancer Diagnostics Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-04
Pages: 96
USD 3950.00 (Single User License)
Global Cancer Diagnostics Service Market Insights, Forecast to 2030
Market Analysis and Insights: Global Cancer Diagnostics Service Market
Published: 2024-04-09
Pages: 105
USD 4900.00 (Single User License)
Global Cancer Diagnostics Service Market Research Report 2024
The global Cancer Diagnostics Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-08
Pages: 83
USD 2900.00 (Single User License)